Case Type: Mergers & Acquisitions

Fortress Value Acquisition Corp. II (FAII) relating to its proposed merger with ATI Physical Therapy. Under the terms of the agreement, FAII will acquire ATI through a reverse merger, with ATI emerging as a publicly traded company.

Starboard Value Acquisition Corp. (SVAC) relating to its proposed merger with Cyxtera Technologies, Inc. Under the terms of the agreement, SVAC will acquire Cyxtera through a reverse merger, with Cyxtera emerging as a publicly traded company.

Huntington Bancshares, Inc. (HBAN) relating to its proposed merger with TCF Financial Corporation. Under the terms of the agreement, TCF shareholders will receive 3.0028 shares of Huntington per share they own.

Viking Energy Group, Inc. (VKIND) relating to its proposed merger with Camber Energy, Inc. Under the terms of the agreement, VKIND shareholders are expected to receive a 1:1 ratio of newly issued Camber common stock per share they own..

Tribune Publishing Company (TPCO) relating to its proposed acquisition by Alden Global Capital. Under the terms of the agreement, TPCO shareholders are expected to receive $17.25 per share they own.

Enable Midstream Partners LP (ENBL) relating to its proposed merger with Energy Transfer LP. Under the terms of the agreement, ENBL shareholders are expected to receive 0.8595 shares of ET per share they own.

Aegion Corp. (AEGN) relating to its proposed acquisition by New Mountain Capital, LLC. Under the terms of the agreement, AEGN shareholders will receive $26.00 per share they own.

Bank of Fincastle (BFTL) relating to its proposed merger with First National Corp. Under the terms of the agreement, BFTL shareholders may receive either $3.30 in cash or 0.1649 shares of First National common stock, or a combination of 80% First National stock and 20% cash per share of BTFL they own.

Climate Change Crisis Real Impact I Acquisition Corp. (CLII) relating to its proposed merger with EVgo Services LLC. Under the terms of the agreement, CLII will acquire EVgo through a reverse merger, with EVgo emerging as a publicly traded company.

CM Life Sciences, Inc. (CMLF) relating to its proposed merger with Sema4. Under the terms of the agreement, CMLF will acquire Sema4 through a reverse merger, with Sema4 emerging as a publicly traded company.